Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.
#DYK that more than 60 billion doses of safe, effective generic prescription medicines are made in the U.S. annually? Learn more #RxFacts about #medsintheUS:
In a story on the benefits of biologics, @glamourmag recognizes the ongoing issue of patient affordability.
Thankfully, further #biosimilar development can successfully provide lifesaving medicines at lower costs for millions of Americans.
The Increasing Access to Biosimilars Act will enhance patient access to #biosimilars by:
✅ Creating a shared savings demonstration program that could save more than $4 billion for seniors and $12 billion for the Medicare program over the next 10 years. https://bit.ly/35LXyFQ
Meet #AAMboard member Vince Mancinelli II, President of Rhodes Pharmaceuticals L.P. https://accessiblemeds.org/about/our-board/vince-mancinelli-ii #AAMBoard
From @PharmaPinkSheet "Association for Accessible Medicines makes a case for lowering prices in Part D through benefit design reforms enabling quicker and better access to first generics." #DoesntAddUp https://accessiblemeds.org/resources/reports/new-evidence-shows-medicare-part-d-plans-continue-fail-get-new-generics-seniors
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
© 2021 Association for Accessible Medicines (AAM), All Rights Reserved.